|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 符合贸易要求的车载称重显示文摘在过去的10年中,NORAC系统国际组织从设想中形成一套车载称重理念,许多人都认为要想达到商业的真实性是不可能的。 | Vaurie Murray 许曼婷(译) 周祖濂(校对) | 2007 | 衡器2007，36，5： | 2 |
| 2 | Treatment rationale and study design for a phaseⅢ,double-blind,placebo-control ed study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced n显示文摘 | Paz-Ares LG Altug S Vaury AT | | 0，，： | 1 |
| 3 | Treatment rationale and study design for a phase Ⅲ, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus Cisplatin for advanced non-squamous non-small cell lung cancei显示文摘 | Paz -Ares LG Altug S Vaury AT | 2010 | BMC cancer2010，10，： | 1 |
| 4 | Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatoeellular careinoma显示文摘 | Yakieier MC Legoix P Vaury C | 2001 | Oneogene2001，20，37： | 1 |
| 5 | Treatment rationale and study design for a phase Ⅲ, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care im- mediately following induction treatment with pemetrexed plus cisplatin for advanced non-squamous non-small cell lung cancer 显示文摘 | Paz-Ares LG Ahug S Vaury AT | 2010 | BMC Cancer2010，10，1： | 1 |
| 6 | Lack of so- matic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene显示文摘 | Medhioub M Vaury C Hamelin R | 2000 | Int J Cancer2000，87，6： | 1 |
| 7 | Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma显示文摘 | Yakicier M C Legoix P Vaury C | 2001 | Oncogene2001，20，37： | 1 |
| 8 | Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene 显示文摘 | Medhioub M Vaury C Hamelin R | 2000 | Int J Cancer2000，87，6： | 1 |
| 9 | Treatment ra- tioale and study design for a phase Ⅲ, double-blind, placebo- controlled study of maintenance pemrtrexed plus best support- ive care versus best supportive care immediately following in- duction treatment with pemetrexed plis cisplatin for advanced nonsquamous non-small cell lung cancer显示文摘 | Paz Ares L G Altug S Vaury A T | 2010 | BMC Cancer2010，10，1： | 1 |
| 10 | Coupling of enhancer and insulator properties identified in two retrotransposons modulates their mutagenic impact on nearby genes 显示文摘 | Conte C Dastugue B Vaury C | 2002 | Molecular and Cellular Biology2002，22，6： | 1 |
| 11 | Systematic notes on palearctic birds显示文摘 | Vaurie C | 1955 | American Museum Novitiates1955，1733，1： | 1 |
| 12 | Treatment rationale and study design for a phase Ⅲ, double - blind, placebo - con - trolled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treat- ment with pemetrexed plus Cisplatin for advanced non - squamous non - small cell lung cancer 显示文摘 | Paz - Ares L G Ahug S Vaury A T | | BMC cancer0，10，： | 1 |
| 13 | Hepatoeellular carcinoma and primary biliary cirrhosis: a new case显示文摘 | Terris G de la Lande P Vaury P | 1982 | Gastroenterol Clin Biol1982，6，67： | 1 |
| 14 | A survey of the birds of Mongolia 显示文摘 | Vaurie C | 1964 | Bull A- mer Mus Nat Hist1964，127，3： | 1 |
| 15 | Treatment rationale and study design for a phase Ⅲ, double- blind, placebo- con- trolled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treat-ment with pemetrexed plus cisplatin for advanced nonsquamous non --small cell lung cancer显示文摘 | Paz-Ares L G Altug S Vaury A T | 2010 | BMC Cancer2010，8，10： | 1 |
| 16 | Exonic duplication of the hepatocyte nuclear factor-1beta gene(transcription factor 2,hepatic) as a cause of maturity onset diabetes of the young type 5显示文摘 | Carette C Vaury C Barthelemy A | 2007 | J Clin Endocrinol Metab2007，92，： | 1 |
| 17 | Treatment rationale and study design for a phase Ⅲ,double-blind,placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced 显示文摘 | Paz-Ares LG Altug S Vaury AT | | 0，，： | 1 |
| 18 | Treatment rationaleand study design for a phase 瓜,double-blind,placebo-con-trolled study of maintenance pemetrexed plus best supportivecare versus best supportive care immediately following induc-tion treatment with pemetrexed plus cisplatin for advancednonsquamous non-small cell lung cancer 显示文摘 | Paz-Ares LG Altug S Vaury AT | 2010 | BMC Cancer2010，10，： | 1 |
| 19 | The status of Larus relictus and of other hooded gulls from central Asia显示文摘 | Vaurie C | 1962 | Auk1962，79，： | 1 |
| 20 | Treatment rationale andstudy design for a phaseⅢ,double-blind,placebo-controlledstudy of maintenance pemetrexed plus best supportive care versusbest supportive care immediately following induction treatmentwith pemetrexed plus cisplatin for advanced non-squamous non-small cell lung cancer显示文摘 | Paz-Ares LG Altug S Vaury AT | 2010 | BMC Cancer2010，10，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员